These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 35702804)

  • 1. Nano-Based Drug Delivery of Anticancer Chemotherapeutic Drugs Targeting Breast Cancer.
    Behl A; Chhillar AK
    Recent Pat Anticancer Drug Discov; 2023; 18(3):325-342. PubMed ID: 35702804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A targeted nanoplatform co-delivering chemotherapeutic and antiangiogenic drugs as a tool to reverse multidrug resistance in breast cancer.
    Tian F; Dahmani FZ; Qiao J; Ni J; Xiong H; Liu T; Zhou J; Yao J
    Acta Biomater; 2018 Jul; 75():398-412. PubMed ID: 29874597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Review on Targeting Nanoparticles for Breast Cancer.
    Alqaraghuli HGJ; Kashanian S; Rafipour R
    Curr Pharm Biotechnol; 2019; 20(13):1087-1107. PubMed ID: 31364513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combinational drug delivery using nanocarriers for breast cancer treatments: A review.
    Olov N; Bagheri-Khoulenjani S; Mirzadeh H
    J Biomed Mater Res A; 2018 Aug; 106(8):2272-2283. PubMed ID: 29577607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of polymeric nanoparticle intracellular targeting overcomes chemodrug resistance in human primary patient breast cancer cells.
    Abou-El-Naga AM; Mutawa G; El-Sherbiny IM; Mousa SA
    Int J Nanomedicine; 2018; 13():8153-8164. PubMed ID: 30555232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug delivery approaches for breast cancer.
    Singh SK; Singh S; Lillard JW; Singh R
    Int J Nanomedicine; 2017; 12():6205-6218. PubMed ID: 28883730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent strategies to overcome breast cancer resistance.
    Khan MM; Yalamarty SSK; Rajmalani BA; Filipczak N; Torchilin VP
    Crit Rev Oncol Hematol; 2024 May; 197():104351. PubMed ID: 38615873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nano-drug delivery system for the treatment of multidrug-resistant breast cancer: Current status and future perspectives.
    Gao L; Meng F; Yang Z; Lafuente-Merchan M; Fernández LM; Cao Y; Kusamori K; Nishikawa M; Itakura S; Chen J; Huang X; Ouyang D; Riester O; Deigner HP; Lai H; Pedraz JL; Ramalingam M; Cai Y
    Biomed Pharmacother; 2024 Oct; 179():117327. PubMed ID: 39216449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Star polyester-based folate acid-targeting nanoparticles for doxorubicin and curcumin co-delivery to combat multidrug-resistant breast cancer.
    Guo F; Yu N; Jiao Y; Hong W; Zhou K; Ji X; Yuan H; Wang H; Li A; Wang G; Yang G
    Drug Deliv; 2021 Dec; 28(1):1709-1721. PubMed ID: 34463174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance.
    Liu J; Wei T; Zhao J; Huang Y; Deng H; Kumar A; Wang C; Liang Z; Ma X; Liang XJ
    Biomaterials; 2016 Jun; 91():44-56. PubMed ID: 26994877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Perspectives on Nanoparticle-based Targeted Drug Delivery Approaches in Breast Cancer Treatment.
    Pandey P; Khan F; Maqsood R; Upadhyay TK
    Endocr Metab Immune Disord Drug Targets; 2023; 23(10):1291-1302. PubMed ID: 36924095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticle delivery of anticancer drugs overcomes multidrug resistance in breast cancer.
    Yuan Y; Cai T; Xia X; Zhang R; Chiba P; Cai Y
    Drug Deliv; 2016 Nov; 23(9):3350-3357. PubMed ID: 27098896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticle-mediated targeted drug delivery for breast cancer treatment.
    Liyanage PY; Hettiarachchi SD; Zhou Y; Ouhtit A; Seven ES; Oztan CY; Celik E; Leblanc RM
    Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):419-433. PubMed ID: 31034927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanotargeted agents: an emerging therapeutic strategy for breast cancer.
    Du M; Ouyang Y; Meng F; Ma Q; Liu H; Zhuang Y; Pang M; Cai T; Cai Y
    Nanomedicine (Lond); 2019 Jul; 14(13):1771-1786. PubMed ID: 31298065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-based Nanoparticles for the Targeted Delivery of Anticancer Drugs: A Review.
    Khodaverdi H; Zeini MS; Moghaddam MM; Vazifedust S; Akbariqomi M; Tebyaniyan H
    Curr Drug Deliv; 2022; 19(10):1012-1033. PubMed ID: 35078396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor-Mediated Targeting in Breast Cancer through Solid Lipid Nanoparticles and Its Mechanism.
    Malik Z; Parveen R; Abass S; Irfan Dar M; Husain SA; Ahmad S
    Curr Drug Metab; 2022; 23(10):800-817. PubMed ID: 35430962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
    Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
    Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing the cytotoxicity of doxorubicin in breast cancer MCF-7 cells with multidrug resistance using a mesoporous silica nanoparticle drug delivery system.
    Wang X; Teng Z; Wang H; Wang C; Liu Y; Tang Y; Wu J; Sun J; Wang H; Wang J; Lu G
    Int J Clin Exp Pathol; 2014; 7(4):1337-47. PubMed ID: 24817930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted multidrug delivery system to overcome chemoresistance in breast cancer.
    Tang Y; Soroush F; Tong Z; Kiani MF; Wang B
    Int J Nanomedicine; 2017; 12():671-681. PubMed ID: 28176940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.